Singapore investing billions more into biomedical R&D

Impatient to see a big payback in new jobs and companies in return for its huge investment in biomedical R&D, Singapore is setting up a $1 billion fund to help promote ties between the science and technology industries. Singapore is preparing to sink another $12 billion into R&D between 2011 and 2015. The city-state is upping the amount of money devoted to achieving economic success from 65 percent of its funds to 70 percent. Story

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.